February 2022

Koya Medical Secures $26M in Series B Funding, Led by 3x5 Partners

United States - Oregon

3x5 Partners, a venture capital firm focused on investing in solutions that respond to global healthcare and climate needs, led a $26 million Series B funding transaction for Koya Medical. Koya Medical is a healthcare company determined to impact treatments for lymphedema, a painful condition caused by blockage of the lymphatic system. Faegre Drinker guided 3x5 Partners in the transaction, which is funding Koya Medical's plans to accelerate the expansion and commercialization of its Dayspring active compression system, the first active compression treatment enabling movement and mobility that is cleared by the U.S. Food and Drug administration.

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.